Director/PDMR Shareholding - Replacement

Director/PDMR Shareholding - Replacement

Eco Animal Health Group Plc

The issuer advises that the following replaces the ECO Animal Health Group plc 'Director/PDMR Shareholding' announcement released at 09.20 am GMT on February 18, 2015.

The announcement released on 18th February 2015 at 9.20 a.m. contained an omission error. The announcement should have also stated that the Board granted 30,000 new options to Anthony Rawlinson, a director of the company, under the Company’s executive share option scheme. These options will vest on 13^th February 2018.

All other details remain unchanged.

The full corrected version is shown below.

Correction - Issue of Share Options

ECO Animal Health Group plc

(“ECO” or the “Company”)

11 March 2015

The Company announces that on 13^th February 2015, the Board granted new options to certain Directors of the Company under the Company’s executive share option scheme. The options will vest on 13^th February 2018 and have been granted as follows:

Director	Â	Number of options granted	Â	Exercise price
Marc Loomes		100,000		£2.005
Brett Clemo		60,000		£2.005
Julia Trouse		40,000		£2.005
Kevin Stockdale		40,000		£2.005
Anthony Rawlinson		30,000		£2.005

The Company’s total issued share capital with voting rights remains 63,107,421 ordinary shares of 5p each, with one voting right per share.

Enquiries

ECO Animal Health Group plc	Â
Peter Lawrence, Executive Chairman		020 8336 6190
Marc Loomes, CEO		020 8447 8899
Spiro Financial
Anthony Spiro		020 8336 6196
Peel Hunt LLP (Nominated Adviser)
Dan Webster, Richard Brown, Dan Harris		020 7418 8900

ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for animals. Our products for these global growth markets promote well-being. Our financial goals are achieved through the careful and responsible application of science to generate value for our shareholders.

Eco Animal Health Group Plc